Sales and Marketing

Showing 15 posts of 11520 posts found.

shutterstock_273326141

AbbVie poised to acquire Allergan for $63 billion

June 26, 2019 Research and Development, Sales and Marketing AbbVie, Allergan, acqusition, pharma

The industry has been rocked with the announcement of another pharmaceutical mega-merger, as it emerged that AbbVie had sealed an …
w36

FREE WEBINAR: Virtually engaged or engaged virtually?

June 25, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, Within3, pharma

In just over a week, on Wednesday 4 July, Pharmafocus will be collaborating with Healthcare Engagement Solutions firm Within3 to …

FDA knocks back Glenmark’s allergic rhinitis therapy Ryaltris

June 25, 2019 Manufacturing and Production, Sales and Marketing FDA, Glenmark, Ryaltris, US, allergy, pharma

Stocks in Indian pharmaceutical firm Glenmark were sent plummeting to a six-year low after it was confirmed that the FDA …
40773627633_110a1e516d_z

Kamala Harris hopes to make insurance companies cover PrEP at no out-of-pocket cost to patients

June 25, 2019 Manufacturing and Production, Sales and Marketing

Democratic presidential candidate Kamala Harris has introduced a bill which would require all private and public insurance plans to cover …
brexit

The Brexit ‘cliff edge’: How life sciences can survive

June 24, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing UK, brexit, pharma

Characterised by a persistent lack of clarity and a political climate that has everyone guessing from week to week, Brexit …

Pfizer’s Talzenna approved in Europe for HER2- advanced breast cancer with gBRCA1/2 mutations

June 24, 2019 Sales and Marketing Pfizer, breast cancer, oncology, pharma

Pfizer’s oral poly (ADP-ribose) polymerase (PARP) inhibitor Talzenna (talazoparib) has secured approval in Europe from the European Commission, the drugmaker …
novartis_window

Glenmark signs deal with Novartis over distribution in Brazil

June 24, 2019 Sales and Marketing Brazil, Glenmark, Latin America, Novartis, distribution, pharma

Indian firm Glenmark Pharmaceuticals has entered into an agreement with Novartis over the distribution of its respiratory products in Brazil. …
vertex-headquarters

FDA expands Vertex’s cystic fibrosis drug Symdeko in paediatric patients

June 24, 2019 Sales and Marketing FDA, Symdeko, Vertex, cystic fibrosis, pharma

Vertex has announced that the FDA has chosen to expand the existing authorisation on its cystic fibrosis (CF) therapy Symdeko …
16792957331_d9572dbdf4_z

FDA approve libido enhancing drug for women with low sexual desire

June 24, 2019 Sales and Marketing FDA, HSDD, health, pharma, viagra, vyleesi

The FDA has approved a new drug for women with low libido.The FDA has approved AMAG Pharmaceuticals’ bremelanotide – sold …

One third of Brits stockpile drugs

June 24, 2019 Sales and Marketing UK, medicine, pharma, pharmaceuticals, stockpiling

A third (33%) of brits stockpile medicines, according to new research from Co-op Health. One in three British people never …
novo_flag

European approval for Novo’s Esperoct in haemophilia A

June 21, 2019 Medical Communications, Sales and Marketing Esperoct, Novo Nordisk, haemophilia, pharma

The European Commission has awarded approval to Novo Nordisk’s extended half-life factor VIII therapy Esperoct (turoctocog alfa pegol, N8-GP) for …
shutterstock_114045100

Sanofi to axe 466 R&D positions in Germany and France

June 21, 2019 Medical Communications, Research and Development, Sales and Marketing Sanofi, pharma

Sanofi has announced that plans to reorganise its research and development operations will result in the losses of 466 jobs …
shutterstock_235920349

GSK offers concessions ahead of planned venture with Pfizer

June 21, 2019 Medical Communications, Sales and Marketing GSK, Pfizer, pharma

The European Commission has said that GlaxoSmithKline has offered concessions to address concerns relating to the British multinational’s planned joint …

Alimera Sciences secures NICE recommendation for uveitis eye implant

June 21, 2019 Medical Communications, Sales and Marketing Alimera Sciences, NICE, UK, pharma, uveitis

Britain’s cost effectiveness body NICE has recommended the use of the fluocinolone acetonide implant, a new treatment option for patients …
The Gateway to Local Adoption Series

Latest content